SOLIGENIX, INC.: Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's Disease
Study DUS-AUBD-01 opens patient enrollment PRINCETON, N.J., Nov. 14, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage ...
Le Lézard2d
Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's Disease
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...
Mena FN4d
H2ocean Launches Educational Webinar Series For Dental Professionals: Educating The Power Of Sea Salt In Oral Care
Understanding Aphthous Ulcers: From Triggers to Treatment: Canker sores, or aphthous ulcers, can cause significant discomfort and disrupt oral health. This webinar explores effective strategies to ...